Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Central Nervous System Neoplasms 4Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Prostatic Neoplasms 2Head and Neck Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Teratoma 1Solitary Fibrous Tumor, Pleural 1Rhabdoid Tumor 1Penile Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Mesothelioma, Malignant 1Liposarcoma 1Leiomyosarcoma 1Inflammatory Breast Neoplasms 1Glioma 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms, Male 1

Interventions

Temozolomide 14Radiotherapy 8Vincristine 5Procarbazine 3Lomustine 3lonafarnib 2imetelstat 2Topotecan 2Radiotherapy, Intensity-Modulated 2Radiotherapy, Conformal 2Psychiatric Rehabilitation 2Irinotecan 2Carboplatin 2veliparib 1transforming growth factor(alpha)-Pseudomonas aeruginosa exotoxin (38) 1palbociclib 1emvododstat 1azurin (50-77) 1Vinblastine 1Semaxinib 1Neoadjuvant Therapy 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Imatinib Mesylate 1GRN163L peptide 1Dexamethasone 1DNA Methylation 1Chemotherapy, Adjuvant 1Calcium Dobesilate 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Oligodendroglioma × Neoadjuvant Therapy × Clear all
NCT00033280 2020-10-22

Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas

Radiation Therapy Oncology Group

Phase 2 Completed
42 enrolled
CNS

Glioma, Oligodendroglioma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡